Overview

Clinical Study of Transplanting Human Retinal Pigment Epithelial Cells for Treatment of Macular Degeneration

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This study is an open-label investigation of the safety and preliminary efficacy of the subretinal transplantation of human retinal pigment epithelial cells on Macular Degeneration.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai East Hospital
Collaborator:
Eyecure Therapeutics Inc.